Upon approval of the drug, the company said it intended to continue the program as part of a patient care program designed to assist, support and educate patients receiving prGCD therapy

Melogliptin significantly reduced HbA1c from baseline as compared to placebo with a mean average reduction of 0.75 percent in patients receiving 50-mg twice-daily doses and 0.60 percent in patients receiving 100-mg once-daily doses...The study population has been modified to evaluate patients receiving first-line chemotherapy, rather than those receiving second-line chemotherapy

Theratechnologies Inc., of Montreal, reported results from a pharmacokinetic/pharmacodynamic evaluation of tesamorelin after single and multiple administrations of 2 mg once daily for 14 consecutive days, in healthy volunteers and HIV-positive patients receiving stable antiretroviral regimens

Mean time to first repeat paracentesis following a baseline procedure was 55 days with aflibercept, compared with 23 days for patients receiving placebo (p = 0.0019

Johnson & Johnson, of New Brunswick, N.J., said a new analysis demonstrated that a greater proportion of patients with moderately to severely active rheumatoid arthritis who had prior treatment with antitumor necrosis factor-alpha agents and who received subcutaneous injections of Simponi (golimumab) once every four weeks experienced significant improvements in signs and symptoms through week 24, compared with patients receiving placebo

In 177 patients receiving radiotherapy for inoperable NSCLC, the randomized, double-blind, placebo-controlled trial assessed the radio-enhancing activity and safety of perifosine co-administration

Patients receiving the 1,200-mg dose will be transitioned to the 800 mg dose to continue therapy

Centocor Ortho Biotech Inc., of Horsham, Pa., and Schering-Plough Corp., of Kenilworth, N.J., said long-term findings from a Phase IIIb SONIC study in patients with moderately to severely active Crohn's disease showed that a greater proportion of those receiving Remicade (infliximab) maintained steroid-free remission at one year, compared to patients receiving the immune suppressant azathioprine alone

Logical Therapeutics Inc., of Waltham, Mass., and Medinox Inc., of Carlsbad, Calif., said a double-blind trial comparing naproxen prodrug LT-NS001 to naproxen showed that patients receiving LT-NS001 experienced significantly fewer endoscopically confirmed gastric ulcers...The subset of patients receiving only topical corticosteroids, which were tapered between weeks four and 16 did, in fact, flare, while the 0.4 mg/kg LX211 dose group did to a much lesser extent

Of the 12 patients receiving KRN5500, eight had improved pain scores with one patient showing 100 percent improvement and four having no change in pain response

The study revealed higher blood levels of docetaxel during and immediately following infusion of the study drug in patients receiving ANX-514 relative to those getting Taxotere, but at 10 minutes after the completion of infusion, docetaxel blood levels were comparable and remained so through the end of the observation period

The study will evaluate safety and efficacy in patients receiving one or two doses of Excellarate compared to placebo controls

Agile Therapeutics Inc., of Princeton, N.J., reported data showing that patients receiving AG200-15, its low-dose weekly contraceptive patch, had consistent ethinyl estradiol (EE) and levonorgestrel hormone levels over three cycles and within range of low-dose oral contraceptives

Patients will be randomized into one of four dosing cohorts of Locteron administered once every two weeks or a control arm consisting of PEG-Intron administered every week, with all patients receiving weight-based ribavirin

patients receiving steroids alone

A total of seven patients have been treated, with six patients receiving treatment for more than one month

Patients receiving 600 mg of Droxidopa showed a mean improvement in arterial blood pressure

The two-year survival rate was nearly doubled at 50.8 percent for Vidaza patients vs. 26.2 percent for patients receiving conventional care (p = 0.0001...The data, which were published in Blood, confirmed that unrelated donors with the KIR B haplotype conferred a significant survival benefit to patients to AML patients receiving transplantation therapy

Osiris Therapeutics Inc., of Columbia, Md., said final two-year results from its Phase I trial evaluating Prochymal for the treatment of acute myocardial infarction found heart attack patients receiving the intravenous therapy had lower rates of adverse events and significantly improved heart function...Also, patients receiving Prochymal had a significant and durable improvement in cardiac function